way 120491 has been researched along with Cardiovascular Stroke in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colatsky, TJ; Harvey, C; Kitzen, JM; McCallum, JD; Morin, ME; Oshiro, GT | 1 |
1 other study(ies) available for way 120491 and Cardiovascular Stroke
| Article | Year |
|---|---|
Potassium channel activators cromakalim and celikalim (WAY-120,491) fail to decrease myocardial infarct size in the anesthetized canine.
Topics: Animals; Benzopyrans; Coronary Circulation; Coronary Vessels; Cromakalim; Disease Models, Animal; Dogs; Hemodynamics; Indoles; Myocardial Infarction; Perfusion; Potassium Channels; Pyrroles; Regional Blood Flow | 1992 |